title: Fingerprint CD34 immunopositivity to distinguish neurofibroma from an early/paucicellular desmoplastic melanoma can be misleading.
authors.affiliation: Division of Dermatopathology, Department of Dermatology, Columbia University, New York, NY, 10032, USA. sh28@columbia.edu.
authors.forename: Sameera
authors.initials: S
authors.lastname: Husain
authors.forename: David N
authors.initials: DN
authors.lastname: Silvers
mesh_terms: D018952:Antigens, CD34 / Q000378:metabolism*; D006801:Humans; D008545:Melanoma / Q000175:diagnosis*; D009455:Neurofibroma / Q000175:diagnosis*; D012878:Skin Neoplasms / Q000175:diagnosis*
chemical_list: D018952:Antigens, CD34
keywords: early/paucicellular desmoplastic melanoma; fingerprint CD34 immunopositivity; neurofibroma